(R)-Pemetrexed
CAS: 182009-04-7
Ref. 3D-HHA00904
| 1mg | 105.00 € | ||
| 2mg | 168.00 € | ||
| 5mg | 210.00 € | ||
| 10mg | 336.00 € | ||
| 25mg | 473.00 € |
Product Information
(R)-Pemetrexed is an anticancer drug that inhibits the growth of cancer cells by blocking the enzymes involved in DNA and RNA synthesis. It is a multi-targeted inhibitor that targets several key enzymes, including thymidylate synthase, dihydrofolate reductase, and glycinamide ribonucleotide formyltransferase. (R)-Pemetrexed induces apoptosis in cancer cells by disrupting protein synthesis and causing cell death. This drug is excreted primarily through urine and has been shown to be effective against a variety of tumors, including lung cancer and mesothelioma. (R)-Pemetrexed also has kinase inhibitory activity, which may contribute to its anticancer effects. This analog has been tested on human and Chinese hamster cells with promising results. In addition, (R)-Pemetrexed can be used in combination with tolvaptan for enhanced efficacy against certain types of cancer.
Chemical properties
Technical inquiry about: 3D-HHA00904 (R)-Pemetrexed
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
